Ontology highlight
ABSTRACT:
SUBMITTER: Kumar K
PROVIDER: S-EPMC6350255 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
Journal of medicinal chemistry 20180821 17
DYRK1A has been implicated as an important drug target in various therapeutic areas, including neurological disorders and oncology. DYRK1A has more recently been shown to be involved in pathways regulating human β-cell proliferation, thus making it a potential therapeutic target for both Type 1 and Type 2 diabetes. Our group, using a high-throughput phenotypic screen, identified harmine that is able to induce β-cell proliferation both in vitro and in vivo. Since harmine has suboptimal kinase sel ...[more]